Man Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-109,991
| Closed | -$7.5M | – | 1918 |
|
|
2024
Q1 | $7.5M | Sell |
109,991
-125,885
| -53% | -$8.58M | 0.02% | 781 |
|
|
2023
Q4 | $14.8M | Buy |
+235,876
| New | +$14.8M | 0.04% | 484 |
|
|
2023
Q3 | – | Sell |
-131,711
| Closed | -$7.39M | – | 700 |
|
|
2023
Q2 | $7.39M | Buy |
+131,711
| New | +$7.39M | 0.02% | 729 |
|
|
2022
Q3 | – | Hold |
0
| – | -$3.39M | – | 2013 |
|
|
2022
Q2 | – | Sell |
-61,690
| Closed | -$3.87M | – | 928 |
|
|
2022
Q1 | $3.87M | Buy |
+61,690
| New | +$3.87M | 0.01% | 995 |
|
|
2021
Q4 | – | Sell |
-24,759
| Closed | -$2.77M | – | 1895 |
|
|
2021
Q3 | $2.77M | Buy |
+24,759
| New | +$2.77M | 0.01% | 1071 |
|
|
2021
Q2 | – | Sell |
-1,814
| Closed | -$221K | – | 1897 |
|
|
2021
Q1 | $221K | Sell |
1,814
-23,012
| -93% | -$2.8M | ﹤0.01% | 1725 |
|
|
2020
Q4 | $3.8M | Buy |
24,826
+13,120
| +112% | +$2.01M | 0.02% | 946 |
|
|
2020
Q3 | $979K | Sell |
11,706
-73,581
| -86% | -$6.15M | ﹤0.01% | 1376 |
|
|
2020
Q2 | $6.27M | Buy |
85,287
+75,081
| +736% | +$5.52M | 0.03% | 565 |
|
|
2020
Q1 | $433K | Sell |
10,206
-36,188
| -78% | -$1.54M | ﹤0.01% | 1302 |
|
|
2019
Q4 | $2.83M | Buy |
+46,394
| New | +$2.83M | 0.01% | 1218 |
|
|
2019
Q2 | – | Sell |
-50,959
| Closed | -$1.82M | – | 1890 |
|
|
2019
Q1 | $1.82M | Buy |
+50,959
| New | +$1.82M | 0.01% | 1366 |
|
|
2018
Q4 | – | Sell |
-8,821
| Closed | -$392K | – | 1939 |
|
|
2018
Q3 | $392K | Buy |
+8,821
| New | +$392K | ﹤0.01% | 1878 |
|